4.7 Article

Elucidation of the Mechanism Underlying the Anti-Inflammatory Properties of (S)-(+)-Carvone Identifies a Novel Class of Sirtuin-1 Activators in a Murine Macrophage Cell Line

Journal

BIOMEDICINES
Volume 9, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/biomedicines9070777

Keywords

aging; inflammation; monoterpene; NF-kappa B; Sirtuin-1; Sirtuin-1 activating compound

Funding

  1. European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Program [POCI-01-0145-FEDER-CARTILFACTORY, CENTRO-01-0145-FEDER-HealthyAging2020, POCI-01-0145-FEDER-028424, CENTRO-01-0145-FEDER-007440, UIDB/04539/2020, UIDP/04539/2020, SFRH/79600/2011]

Ask authors/readers for more resources

The study revealed that (S)-(+)-carvone can inhibit inflammation by modulating SIRT1 activity and NF-kappa B/p65 acetylation, suggesting its potential as an anti-inflammatory agent.
The signaling pathways involved in age-related inflammation are increasingly recognized as targets for the development of preventive and therapeutic strategies. Our previous study elucidated the structure-activity relationship of monoterpene compounds derived from p-menthane as potential anti-inflammatory drugs and identified (S)-(+)-carvone as the most potent among the compounds tested. This study aims at identifying the molecular mechanism underlying the anti-inflammatory properties of (S)-(+)-carvone. The murine macrophage cell line, Raw 264.7, was stimulated with bacterial lipopolysaccharide (LPS) to simulate inflammation. Western blot was used to assess protein levels and post-translational modifications. The subcellular localization of NF-kappa B/p65 was visualized by immunocytochemistry. An in vitro fluorometric assay was used to measure Sirtuin-1 (SIRT1) activity. (S)-(+)-carvone inhibited LPS-induced JNK1 phosphorylation, but not that of p38 and ERK1/2 and also did not affect the phosphorylation and degradation of the NF-kappa B inhibitor, I kappa B-alpha. Accordingly, (S)-(+)-carvone did not affect LPS-induced phosphorylation of NF-kappa B/p65 on Ser536 and its nuclear translocation, but it significantly decreased LPS-induced I kappa B-alpha resynthesis, a NF-kappa B-dependent process, and NF-kappa B/p65 acetylation on lysine (Lys) 310. Deacetylation of that Lys residue is dependent on the activity of SIRT1, which was found to be increased by (S)-(+)-carvone, while its protein levels were unaffected. Taken together, these results show that (S)-(+)-carvone is a new SIRT1 activator with the potential to counteract the chronic low-grade inflammation characteristic of age-related diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available